With over two decades of experience in the Central and Eastern European healthcare sector, Grove’s expertise in providing market assessment and pharmaceutical consulting services in the region is proven by the success of those with which it has worked over that time. Grove’s full-time in-country expertise and the resultant depth and breadth of knowledge of the healthcare sector in the Czech Republic is key to its clients’ success. Grove’s ad-hoc consulting services primarily relate to the provision of on-going support for market development.
Over the past twenty years, Grove’s regulatory consultants have provided expert advice and guidance to clients across the Central and Eastern European region. Questions addressed have covered the following areas and more:
‘Due to the registration pathway (repeat-use MRP) in Central and Eastern Europe, could you (Grove) assess the registration risks for us in Poland, Romania, Czech, Hungary, Slovakia, Slovenia, Croatia, Estonia, Latvia and Lithuania. We would also like you to evaluate the potential impact on our currently registered product’s SPC and identify any likely future developments.
Please provide us with strategic advice with regards to the likelihood of successfully registering our products in all ten countries. What do we need to do in terms of risk mitigation and/or other activities to maximize the probability of successful registration?’
‘We recognize that there is significant business growth potential in Poland. We would like Grove to undertake a market research study so that we are able to gain a better understanding of the size of the multiple sclerosis market, the number of patients, currentMS drug treatments and the potential for our new MS medicinal product. Furthermore, we would ask Grove to provide us with insight in the following areas: hospital tenders; full supply chain and wholesale distribution for MS products; competitor insights.’
MARKET ASSESSMENT CZECH REPUBLIC
Grove’s industry experts based locally in the Czech Republic and within the wider region work as a team to provide a range of services for those either looking to enter the pharma market or develop their presence further into new areas within the market. Services include:
- Market entry studies
- Opportunity evaluation
- Routes to market
- Regulatory intelligence
- Regulatory risk assessment
- Regulatory strategies
- Regulatory consulting for compassionate use programs
MARKET DEVELOPMENT CZECH REPUBLIC – PHARMACEUTICAL CONSULTING SERVICES
Pharmaceutical consulting is Grove’s core specialization and strength. Dependent on need (on-going or ad-hoc), Grove’s in-country consultants work with clients established within the Czech market to develop their business in a number of areas. Key areas of expertise include:
- PR and marketing support
- Monitoring market and industry change
- Sales force training
- Named patient supply, orphan drugs
- Compassionate use programs
- Orphan drugs
- Access to key opinion leaders and healthcare decision makers
- Pricing and reimbursement monitoring
- Competitor analysis
- Product portfolio expansion
Grove’s expert consulting spans across the following product areas:
- Pharmaceuticals/medicines/drugs/medicinal products
- Medical devices
- Biologics
- Cosmetics
- Food and dietary supplements
